Indications and uses
For temporary relief of exhaustion and restlessness, metallic taste and dyspepsia and menstrual pain.
For temporary relief of exhaustion and restlessness, metallic taste and dyspepsia and menstrual pain.
10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age.
Squalene 8X, Cholesterinum 12X, Estrogen 12X, Progesterone 12X, Aspartame 30X, Benzalkonium chloride 30X, Formalinum 30X, Methylene chloride 30X, Methylparaben 30X, Propylparaben 30X, Sodium benzoate 30X, Sodium citrate 30X, Titanium dioxide 30X, Zincum oxydatum 30X, Arsenicum Album 30X, Lycopodium Clavatum 30X, Nux Vomica 30X, Phosphoricum Acidum 30X, Phosphorus 30X, Adrenocorticotrophin 30X, 60X, 200X, Xylitol 30X, 60X, 200X, Isopropyl palmitate 30X, 60X, 200X, Petroleum jelly 30X, 60X, 200X, Salicylicum acidum 30X, 60X, 200X, Aceticum acidum 30X, 60X, 200X, Cortisone Aceticum 30X, 60X, 200X, Benzoicum acidum 30X, 60X, 200X, Lacticum acidum 30X, 60X, 200X, Eugenol 30X, 60X, 200X, Boricum acidum 30X, 60X, 200X, Stearyl alcohol 30X, 60X, 200X, Resorcinum 30X, 60X, 200X, Phenylbutazone 30X, 60X, 200X, Plumbum metallicum 30X, 60X, 200X, Chlorinum 30X, 60X, 200X
For temporary relief of exhaustion and restlessness, metallic taste and dyspepsia and menstrual pain.
If pregnant or breast-feeding, ask a health care professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Do not use if tamper evident seal is broken or missing.
Store in cool, dry place.
10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age.
Demineralized water, 25% Ethanol.
In case of overdose, get medical help or contact a Poison Control Center right away.
For temporary relief of exhaustion and restlessness, metallic taste and dyspepsia and menstrual pain.
Distributed by:
BIOACTIVE NUTRITIONAL
Melbourne, FL 32935
For Nutritional Information write:
BioActive Nutritional, Inc.
1803 N. Wickham Rd.
Melbourne, FL 32935
BioActive Homeopathic
LIPOTOX
1 FL OZ (30 ml)
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 43857-0143-1 | 2023-06-08 | C162847 | 48780-1 | 9d75b9d0-b431-f424-e053-dadaa90a57ce | Drug Facts |
| 43857-0143-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-b431-f424-e053-dadaa90a57ce | Drug Facts |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ACETIC ACID | ACTIVE INGREDIENT | Q40Q9N063P | 1 | |
| ARSENIC ACID | ACTIVE INGREDIENT | N7CIZ75ZPN | 1 | |
| ASPARTAME | ACTIVE INGREDIENT | Z0H242BBR1 | 1 | |
| BENZALKONIUM CHLORIDE | ACTIVE INGREDIENT | F5UM2KM3W7 | 1 | |
| BENZOIC ACID | ACTIVE INGREDIENT | 8SKN0B0MIM | 1 | |
| BENZYL ALCOHOL | ACTIVE INGREDIENT | LKG8494WBH | 1 | |
| BORIC ACID | ACTIVE INGREDIENT | R57ZHV85D4 | 1 | |
| CHLORINE | ACTIVE INGREDIENT | 4R7X1O2820 | 1 | |
| CHOLESTEROL | ACTIVE INGREDIENT | 97C5T2UQ7J | 1 | |
| CORTICOTROPIN | ACTIVE INGREDIENT | K0U68Q2TXA | 1 | |
| CORTISONE ACETATE | ACTIVE INGREDIENT | 883WKN7W8X | 1 | |
| Estradiol | ACTIVE INGREDIENT | 4TI98Z838E | 1 | |
| ESTRIOL | ACTIVE INGREDIENT | FB33469R8E | 1 | |
| ESTRONE | ACTIVE INGREDIENT | 2DI9HA706A | 1 | |
| EUGENOL | ACTIVE INGREDIENT | 3T8H1794QW | 1 | |
| FORMALDEHYDE | ACTIVE INGREDIENT | 1HG84L3525 | 1 | |
| ISOPROPYL PALMITATE | ACTIVE INGREDIENT | 8CRQ2TH63M | 1 | |
| LACTIC ACID | ACTIVE INGREDIENT | 33X04XA5AT | 1 | |
| LEAD | ACTIVE INGREDIENT | 2P299V784P | 1 | |
| LYCOPODIUM CLAVATUM SPORE | ACTIVE INGREDIENT | C88X29Y479 | 1 | |
| METHYLENE CHLORIDE | ACTIVE INGREDIENT | 588X2YUY0A | 1 | |
| METHYLPARABEN | ACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| PETROLATUM | ACTIVE INGREDIENT | 4T6H12BN9U | 1 | |
| PHENYLBUTAZONE | ACTIVE INGREDIENT | GN5P7K3T8S | 1 | |
| PHOSPHORIC ACID | ACTIVE INGREDIENT | E4GA8884NN | 1 | |
| PHOSPHORUS | ACTIVE INGREDIENT | 27YLU75U4W | 1 | |
| POTASSIUM SORBATE | ACTIVE INGREDIENT | 1VPU26JZZ4 | 1 | |
| PROGESTERONE | ACTIVE INGREDIENT | 4G7DS2Q64Y | 1 | |
| PROPYLPARABEN | ACTIVE INGREDIENT | Z8IX2SC1OH | 1 | |
| RESORCINOL | ACTIVE INGREDIENT | YUL4LO94HK | 1 | |
| SALICYLIC ACID | ACTIVE INGREDIENT | O414PZ4LPZ | 1 | |
| SODIUM BENZOATE | ACTIVE INGREDIENT | OJ245FE5EU | 1 | |
| SODIUM CITRATE | ACTIVE INGREDIENT | 1Q73Q2JULR | 1 | |
| SORBITOL | ACTIVE INGREDIENT | 506T60A25R | 1 | |
| SQUALENE | ACTIVE INGREDIENT | 7QWM220FJH | 1 | |
| STEARYL ALCOHOL | ACTIVE INGREDIENT | 2KR89I4H1Y | 1 | |
| STRYCHNOS NUX-VOMICA SEED | ACTIVE INGREDIENT | 269XH13919 | 1 | |
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| XYLITOL | ACTIVE INGREDIENT | VCQ006KQ1E | 1 | |
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| ACETIC ACID | ACTIVE MOIETY | Q40Q9N063P | 1 | |
| ANHYDROUS CITRIC ACID | ACTIVE MOIETY | XF417D3PSL | 1 | |
| ARSENIC ACID | ACTIVE MOIETY | N7CIZ75ZPN | 1 | |
| ASPARTAME | ACTIVE MOIETY | Z0H242BBR1 | 1 | |
| BENZALKONIUM | ACTIVE MOIETY | 7N6JUD5X6Y | 1 | |
| BENZOIC ACID | ACTIVE MOIETY | 8SKN0B0MIM | 1 | |
| BENZYL ALCOHOL | ACTIVE MOIETY | LKG8494WBH | 1 | |
| BORIC ACID | ACTIVE MOIETY | R57ZHV85D4 | 1 | |
| CHLORINE | ACTIVE MOIETY | 4R7X1O2820 | 1 | |
| CHOLESTEROL | ACTIVE MOIETY | 97C5T2UQ7J | 1 | |
| CORTICOTROPIN | ACTIVE MOIETY | K0U68Q2TXA | 1 | |
| CORTISONE | ACTIVE MOIETY | V27W9254FZ | 1 | |
| ESTRADIOL | ACTIVE MOIETY | 4TI98Z838E | 1 | |
| ESTRIOL | ACTIVE MOIETY | FB33469R8E | 1 | |
| ESTRONE | ACTIVE MOIETY | 2DI9HA706A | 1 | |
| EUGENOL | ACTIVE MOIETY | 3T8H1794QW | 1 | |
| FORMALDEHYDE | ACTIVE MOIETY | 1HG84L3525 | 1 | |
| ISOPROPYL PALMITATE | ACTIVE MOIETY | 8CRQ2TH63M | 1 | |
| LACTIC ACID | ACTIVE MOIETY | 33X04XA5AT | 1 | |
| LEAD | ACTIVE MOIETY | 2P299V784P | 1 | |
| LYCOPODIUM CLAVATUM SPORE | ACTIVE MOIETY | C88X29Y479 | 1 | |
| METHYLENE CHLORIDE | ACTIVE MOIETY | 588X2YUY0A | 1 | |
| METHYLPARABEN | ACTIVE MOIETY | A2I8C7HI9T | 1 | |
| PETROLATUM | ACTIVE MOIETY | 4T6H12BN9U | 1 | |
| PHENYLBUTAZONE | ACTIVE MOIETY | GN5P7K3T8S | 1 | |
| PHOSPHORIC ACID | ACTIVE MOIETY | E4GA8884NN | 1 | |
| PHOSPHORUS | ACTIVE MOIETY | 27YLU75U4W | 1 | |
| PROGESTERONE | ACTIVE MOIETY | 4G7DS2Q64Y | 1 | |
| PROPYLPARABEN | ACTIVE MOIETY | Z8IX2SC1OH | 1 | |
| RESORCINOL | ACTIVE MOIETY | YUL4LO94HK | 1 | |
| SALICYLIC ACID | ACTIVE MOIETY | O414PZ4LPZ | 1 | |
| SORBIC ACID | ACTIVE MOIETY | X045WJ989B | 1 | |
| SORBITOL | ACTIVE MOIETY | 506T60A25R | 1 | |
| SQUALENE | ACTIVE MOIETY | 7QWM220FJH | 1 | |
| STEARYL ALCOHOL | ACTIVE MOIETY | 2KR89I4H1Y | 1 | |
| STRYCHNOS NUX-VOMICA SEED | ACTIVE MOIETY | 269XH13919 | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| XYLITOL | ACTIVE MOIETY | VCQ006KQ1E | 1 | |
| ZINC CATION | ACTIVE MOIETY | 13S1S8SF37 | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| BORAGE OIL | INACTIVE INGREDIENT | F8XAG1755S | 1 | |
| CASTOR OIL | INACTIVE INGREDIENT | D5340Y2I9G | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 43857-0143 | 43857-0143-1 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | EMULSION / OPHTHALMIC | 32 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | GEL / NASAL | 429 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | GRANULE, FOR SUSPENSION / ORAL | 128 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET / SUBLINGUAL | 1.6 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | CAPSULE, EXTENDED RELEASE / ORAL | 47 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | INJECTION, SOLUTION / INTRAMUSCULAR | 525 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | SPRAY / NASAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET / ORAL | 17 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET, FILM COATED / ORAL | 15.29 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET, EXTENDED RELEASE / ORAL | 23.27 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | CAPSULE / ORAL | 1.04 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | INJECTION / INTRAMUSCULAR | 885 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | OINTMENT / TOPICAL | 14.9 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET, DELAYED RELEASE / ORAL | 0.01 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 875478e3-ec5f-48c9-879e-6e358d624b24 | 1dc99bcf-e7c3-477d-9cb8-e5d2d8c8c76f | 2023-06-08 | Warnings | 875478e3-ec5f-48c9-879e-6e358d624b24 1dc99bcf-e7c3-477d-9cb8-e5d2d8c8c76f |
Adverse event summaries are temporarily unavailable. Other product information remains available.